Cardinal Health, Inc. (LON:0HTG)
202.62
+7.42 (3.80%)
At close: Nov 7, 2025
Cardinal Health Market Cap
Cardinal Health has a market cap or net worth of 36.75 billion as of November 7, 2025. Its market cap has increased by 75.64% in one year.
Market Cap
36.75B
Enterprise Value
40.24B
Revenue
174.31B
Ranking
n/a
PE Ratio
30.97
Stock Price
202.62
Market Cap Chart
Since October 18, 1993, Cardinal Health's market cap has increased from 708.13M to 36.75B, an increase of 5,090.27%. That is a compound annual growth rate of 13.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 36.75B | 60.76% |
| Dec 31, 2024 | 22.86B | 17.22% |
| Dec 29, 2023 | 19.50B | 16.63% |
| Dec 30, 2022 | 16.72B | 56.07% |
| Dec 31, 2021 | 10.72B | -6.91% |
| Dec 31, 2020 | 11.51B | 3.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.04B |
| GSK plc | 66.53B |
| Haleon | 32.17B |
| Smith & Nephew | 10.74B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.58B |